000			01568 a2200421 4500
005			20250515105551.0
264		0	_c20090302
008			200903s 0 0 eng d
022			_a1768-3254
024	7		_a10.1016/j.ejmech.2007.12.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aRawal, Ravindra K
245	0	0	_aDesign and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents. _h[electronic resource]
260			_bEuropean journal of medicinal chemistry _cDec 2008
300			_a2800-6 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnti-HIV Agents _xchemical synthesis
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Design
650	0	4	_aHIV Reverse Transcriptase _xdrug effects
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHumans
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMolecular Structure
650	0	4	_aReverse Transcriptase Inhibitors _xchemical synthesis
650	0	4	_aStereoisomerism
650	0	4	_aStructure-Activity Relationship
650	0	4	_aThiazolidines _xchemical synthesis
650	0	4	_aVirus Replication _xdrug effects
700	1		_aTripathi, Rajkamal
700	1		_aKatti, S B
700	1		_aPannecouque, Christophe
700	1		_aDe Clercq, Erik
773	0		_tEuropean journal of medicinal chemistry _gvol. 43 _gno. 12 _gp. 2800-6
856	4	0	_uhttps://doi.org/10.1016/j.ejmech.2007.12.015 _zAvailable from publisher's website
999			_c17748957 _d17748957